Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
NCT ID: NCT06207279
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
240 participants
OBSERVATIONAL
2023-09-28
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Correlation Study of Cognitive Function in Patients With Depression
NCT05396989
Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
NCT00478829
The Development of Psychiatric Non-Suicidal Self-Injury Risk Assessment Scale
NCT06603389
AI-Powered Mental Health Screening in University Students
NCT07092085
Long-term Effects ReSet Your Mind - Mechanisms
NCT06072209
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. To choose 20 cases for ARS retesting 7 days after the first ARS evaluation.
3. To evaluate the split half reliability through the Spearman Brown coefficient.
4. To apply principal component analysis for structural validity analysis.
5. Using the Attention Network Test (ANT) and Toronto Hospital Alertness Test (THE) as gold standards, the Pearson correlation coefficient was used for criterion validity analysis.
6. To administrate 60 patients with MDD, ADHD and insomnia disorder testing the discrimination validity of ARS.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Major Depressive Disorder
Patients meeting the diagnostic criteria for Major Depressive Disorder (MDD) according to DSM-5.
rating
rating scales, test ANT
Chronic Insomnia Disorder
Patients meeting the diagnostic criteria for Chronic Insomnia Disorder according to ICSD-3.
rating
rating scales, test ANT
Health Control
Healthy population.
rating
rating scales, test ANT
Attention Deficit and hyperactivity Disorder
Patients meeting the diagnostic criteria for Attention Deficit and hyperactivity Disorder (ADHD) according to DSM-5.
rating
rating scales, test ANT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rating
rating scales, test ANT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Ages between 18 and 60 years old
3. Right-handed
4. Educational level ≥5 years or IQ ≥90, capable of understanding and reading Chinese.
Exclusion Criteria
2. Currently and past history of neurological disorders and physical illnesses with subjectives
3. Consumed alcohol in the week preceding the enrollment
4. Using antidepressants, antipsychotics, mood stabilizers, or other central nervous system-acting drugs for at least 4 weeks in the current episode
5. Undergoing any physical treatments such as ECT, neuromodulation therapy or Traditional Chinese Medicine treatment in the past 6 months
6. Refused to sign the informed consent form
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Sixth Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xueqin Wang
Principle Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xueqin Wang, doctor
Role: PRINCIPAL_INVESTIGATOR
Peking University Sixth Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Sixth Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-056
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.